Clinical Trial

Pycnogenol (French Maritime Pine Bark) for the Treatment of Gulf War Illness

Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
The purpose of this research study is to determine how pycnogenol may reduce Gulf War Illness (GWI) symptom severity. The study will also examine the safety of this treatment and determine the optimal dosage. The investigators believe that GWI involves inflammation in the body and brain that causes fatigue, pain, cognitive disruption, and other symptoms. Botanicals that reduce inflammation may help treat GWI.
Protocol Amendment History 2 changes
notable Primary completion pushed: 2027-05-01 -> 2027-08-01 2026-06-18
minor Completion pushed: 2027-05-01 -> 2027-08-01 2026-06-18
Trial Details
NCT Number NCT07266571
Lead Sponsor University of Alabama at Birmingham
Conditions Gulf War Syndrome
Enrollment 20 participants
Start Date 2026-08-01
Primary Completion 2027-08-01 (estimated)
Study Completion 2027-08-01 (estimated)
Updated on ClinicalTrials.gov 2026-06-17